Do fibrin sealants impact negative outcomes after robot-assisted partial nephrectomy?

Area of Science:

• Urology
• Surgical Innovation
• Oncology

Background:

• Postoperative hemorrhage rates after partial nephrectomy (PN) are low.
• Hemostatic agents are often used despite limited supporting data.
• The cost-effectiveness of fibrin sealants in PN requires evaluation.

Purpose of the Study:

• To assess the impact of fibrin sealant hemostatic agents during robot-assisted partial nephrectomy (RAPN).
• To determine if fibrin sealants reduce complications, blood loss, or hospital stay in RAPN.
• To evaluate the cost-effectiveness of omitting fibrin sealants in RAPN.

Main Methods:

• A retrospective study of 114 patients undergoing RAPN by a single surgeon.
• Comparison of outcomes between patients receiving fibrin sealant (n=74) and those not (n=40).
• Analysis of operative time, warm ischemia time (WIT), blood loss, transfusion rates, and complications.

Main Results:

• Fibrin sealant use did not significantly affect operative time, WIT, or hospital stay.
• Omission of fibrin sealants did not increase blood loss or transfusion rates.
• No association found between fibrin sealant use and increased complications.

Conclusions:

• Perioperative complications after RAPN are rare in experienced hands.
• Fibrin sealants do not decrease complication rates, blood loss, or hospital stay in RAPN.
• Omitting fibrin sealants during RAPN is a safe, effective, and potentially cost-saving strategy.